These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36948133)
1. Protective effect of sodium butyrate on intestinal barrier damage and uric acid reduction in hyperuricemia mice. Li Y; Li H; Wang R; Yu Y; Liu X; Tian Z Biomed Pharmacother; 2023 May; 161():114568. PubMed ID: 36948133 [TBL] [Abstract][Full Text] [Related]
2. Commensal Enterococcus faecalis W5 ameliorates hyperuricemia and maintains the epithelial barrier in a hyperuricemia mouse model. Liu X; Han CH; Mao T; Wu J; Ke LY; Guo YJ; Han RS; Tian ZB J Dig Dis; 2024 Jan; 25(1):44-60. PubMed ID: 38126957 [TBL] [Abstract][Full Text] [Related]
3. Chlorogenic acid supplementation ameliorates hyperuricemia, relieves renal inflammation, and modulates intestinal homeostasis. Zhou X; Zhang B; Zhao X; Lin Y; Wang J; Wang X; Hu N; Wang S Food Funct; 2021 Jun; 12(12):5637-5649. PubMed ID: 34018499 [TBL] [Abstract][Full Text] [Related]
4. Whey Protein Peptide Pro-Glu-Trp Ameliorates Hyperuricemia by Enhancing Intestinal Uric Acid Excretion, Modulating the Gut Microbiota, and Protecting the Intestinal Barrier in Rats. Qi X; Ma Y; Guan K; Zhao L; Ma Y; Wang R J Agric Food Chem; 2024 Feb; 72(5):2573-2584. PubMed ID: 38240209 [TBL] [Abstract][Full Text] [Related]
5. Effects of a Macroporous Resin Extract of Li LZ; Wang XM; Feng XJ; Liu K; Li B; Zhu LJ; Xu WF; Zheng X; Dong YJ; He XL; Guan HR; Ding YY; Wu HS; Zhou CJ; Ye SY; Zhang BB; Lv GY; Chen SH Evid Based Complement Alternat Med; 2023; 2023():9990843. PubMed ID: 36644440 [TBL] [Abstract][Full Text] [Related]
6. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Cui D; Liu S; Tang M; Lu Y; Zhao M; Mao R; Wang C; Yuan Y; Li L; Chen Y; Cheng J; Lu Y; Liu J Phytomedicine; 2020 Jan; 66():153111. PubMed ID: 31790902 [TBL] [Abstract][Full Text] [Related]
7. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats. Chen X; Ge HZ; Lei SS; Jiang ZT; Su J; He X; Zheng X; Wang HY; Yu QX; Li B; Lv GY; Chen SH Biomed Pharmacother; 2020 Dec; 132():110765. PubMed ID: 33120237 [TBL] [Abstract][Full Text] [Related]
8. Folic Acid Protects against Hyperuricemia in C57BL/6J Mice via Ameliorating Gut-Kidney Axis Dysfunction. Wang P; Zhang X; Zheng X; Gao J; Shang M; Xu J; Liang H J Agric Food Chem; 2022 Dec; 70(50):15787-15803. PubMed ID: 36473110 [TBL] [Abstract][Full Text] [Related]
9. Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice. Guo Y; Yu Y; Li H; Ding X; Li X; Jing X; Chen J; Liu G; Lin Y; Jiang C; Liu Z; He Y; Li C; Tian Z Eur J Nutr; 2021 Jun; 60(4):2217-2230. PubMed ID: 33104864 [TBL] [Abstract][Full Text] [Related]
10. Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis. Wei H; Yu C; Zhang C; Ren Y; Guo L; Wang T; Chen F; Li Y; Zhang X; Wang H; Liu J Biomed Pharmacother; 2023 Apr; 160():114308. PubMed ID: 36709599 [TBL] [Abstract][Full Text] [Related]
11. Impaired intestinal barrier function in a mouse model of hyperuricemia. Guo Y; Li H; Liu Z; Li C; Chen Y; Jiang C; Yu Y; Tian Z Mol Med Rep; 2019 Oct; 20(4):3292-3300. PubMed ID: 31432190 [TBL] [Abstract][Full Text] [Related]
12. Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice. Lu YH; Chang YP; Li T; Han F; Li CJ; Li XY; Xue M; Cheng Y; Meng ZY; Han Z; Sun B; Chen LM Int J Biol Sci; 2020; 16(3):529-542. PubMed ID: 32015688 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice. Xu RC; Miao WT; Xu JY; Xu WX; Liu MR; Ding ST; Jian YX; Lei YH; Yan N; Liu HD Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235813 [TBL] [Abstract][Full Text] [Related]
14. Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model. Li Q; Huang Z; Liu D; Zheng J; Xie J; Chen J; Zeng H; Su Z; Li Y Drug Des Devel Ther; 2021; 15():3241-3254. PubMed ID: 34349501 [TBL] [Abstract][Full Text] [Related]
15. Pulsatilla decoction improves DSS-induced colitis via modulation of fecal-bacteria-related short-chain fatty acids and intestinal barrier integrity. Niu C; Hu XL; Yuan ZW; Xiao Y; Ji P; Wei YM; Hua YL J Ethnopharmacol; 2023 Jan; 300():115741. PubMed ID: 36162543 [TBL] [Abstract][Full Text] [Related]
16. Uric acid-lowering effect of harpagoside and its protective effect against hyperuricemia-induced renal injury in mice. Fu Q; Zhang JJ; Zhu QF; Yu LL; Wang F; Li J; He X; Ao JL; Xu GB; Wei MC; Liao XJ; Liao SG Biochem Biophys Res Commun; 2024 Jul; 716():150038. PubMed ID: 38704891 [TBL] [Abstract][Full Text] [Related]
17. Fangyukangsuan granules ameliorate hyperuricemia and modulate gut microbiota in rats. Zhang QZ; Zhang JR; Li X; Yin JL; Jin LM; Xun ZR; Xue H; Yang WQ; Zhang H; Qu J; Xing ZK; Wang XM Front Immunol; 2024; 15():1362642. PubMed ID: 38745649 [TBL] [Abstract][Full Text] [Related]
18. Three important short-chain fatty acids (SCFAs) attenuate the inflammatory response induced by 5-FU and maintain the integrity of intestinal mucosal tight junction. Yue X; Wen S; Long-Kun D; Man Y; Chang S; Min Z; Shuang-Yu L; Xin Q; Jie M; Liang W BMC Immunol; 2022 Apr; 23(1):19. PubMed ID: 35448938 [TBL] [Abstract][Full Text] [Related]
19. Preliminary study on the material basis and mechanism underlying uric acid reduction by Thlaspi arvense L. Ke X; Yang X; Hou C; Wang Y; Zhou Y; Wu T; Yang R J Ethnopharmacol; 2024 Jan; 319(Pt 1):116814. PubMed ID: 37598767 [TBL] [Abstract][Full Text] [Related]
20. Protective Effect of Luminal Uric Acid Against Indomethacin-Induced Enteropathy: Role of Antioxidant Effect and Gut Microbiota. Wada A; Higashiyama M; Kurihara C; Ito S; Tanemoto R; Mizoguchi A; Nishii S; Inaba K; Sugihara N; Hanawa Y; Horiuchi K; Shibuya N; Akiyama M; Okada Y; Watanabe C; Komoto S; Tomita K; Takei F; Hokari R Dig Dis Sci; 2022 Jan; 67(1):121-133. PubMed ID: 33569665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]